Ines Nevelsteen

2.3k total citations · 1 hit paper
64 papers, 1.2k citations indexed

About

Ines Nevelsteen is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ines Nevelsteen has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 25 papers in Cancer Research and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Ines Nevelsteen's work include Breast Cancer Treatment Studies (20 papers), Lymphatic System and Diseases (15 papers) and Breast Lesions and Carcinomas (8 papers). Ines Nevelsteen is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), Lymphatic System and Diseases (15 papers) and Breast Lesions and Carcinomas (8 papers). Ines Nevelsteen collaborates with scholars based in Belgium, United States and Netherlands. Ines Nevelsteen's co-authors include Patrick Neven, Ann Smeets, Giuseppe Floris, Hans Wildiers, Kevin Punie, Nele Devoogdt, Nick Gebruers, Tessa De Vrieze, An De Groef and Christine Desmedt and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and The Journal of Physiology.

In The Last Decade

Ines Nevelsteen

57 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer

2021 442 citations Ayse Bassez, Hanne Vos et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ines Nevelsteen Belgium	16	666	341	264	205	195	64	1.2k
Senem Karabulut Türkiye	18	483 0.7×	310 0.9×	142 0.5×	121 0.6×	185 0.9×	96	1.0k
Bilal Majed France	10	613 0.9×	454 1.3×	138 0.5×	74 0.4×	437 2.2×	15	1.3k
Ho Lee South Korea	21	533 0.8×	517 1.5×	206 0.8×	157 0.8×	164 0.8×	45	1.4k
Samuel A. Funt United States	19	670 1.0×	498 1.5×	371 1.4×	652 3.2×	224 1.1×	100	1.7k
Yvonne H. Datta United States	15	245 0.4×	216 0.6×	74 0.3×	66 0.3×	139 0.7×	24	982
Hendrik Seeliger Germany	24	902 1.4×	609 1.8×	122 0.5×	567 2.8×	235 1.2×	64	1.8k
Sen Shi Japan	14	285 0.4×	448 1.3×	85 0.3×	182 0.9×	197 1.0×	23	1.1k
Hui Sun China	21	382 0.6×	673 2.0×	133 0.5×	604 2.9×	277 1.4×	114	2.2k
Masayuki Tanahashi Japan	19	521 0.8×	517 1.5×	169 0.6×	93 0.5×	229 1.2×	97	1.3k
Bahil Ghanim Austria	27	257 0.4×	379 1.1×	113 0.4×	336 1.6×	202 1.0×	60	1.7k

Countries citing papers authored by Ines Nevelsteen

Since Specialization

Citations

This map shows the geographic impact of Ines Nevelsteen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Nevelsteen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Nevelsteen more than expected).

Fields of papers citing papers by Ines Nevelsteen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ines Nevelsteen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Nevelsteen. The network helps show where Ines Nevelsteen may publish in the future.

Co-authorship network of co-authors of Ines Nevelsteen

This figure shows the co-authorship network connecting the top 25 collaborators of Ines Nevelsteen. A scholar is included among the top collaborators of Ines Nevelsteen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ines Nevelsteen. Ines Nevelsteen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baelen, Karen Van, François Richard, Maria Margarete Karsten, et al.. (2025). Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study. Breast Cancer Research. 27(1). 106–106. 1 indexed citations

Nevelsteen, Ines, et al.. (2025). Hereditary breast cancer beyond BRCA: clinicopathological characteristics and long-term outcomes. Familial Cancer. 24(2). 54–54.

Laenen, Annouschka, Machteld Keupers, Ines Nevelsteen, et al.. (2024). Expression patterns of H3K27me3 for differentiation of breast fibroadenomas and phyllodes tumors. Apmis. 133(1). e13485–e13485. 2 indexed citations

Baelen, Karen Van, Hans Wildiers, Giuseppe Floris, et al.. (2024). Abstract PO3-05-05: The effect of histological breast cancer subtype on progression free survival in patients with CDK4/6 inhibitors. Cancer Research. 84(9_Supplement). PO3–5.

Devoogdt, Nele, Sarah Thomis, An De Groef, et al.. (2023). The Effectiveness of Fluoroscopy-Guided Manual Lymph Drainage as Part of Decongestive Lymphatic Therapy on the Superficial Lymphatic Architecture in Patients with Breast Cancer-Related Lymphoedema: A Randomised Controlled Trial. Cancers. 15(5). 1545–1545. 8 indexed citations

Richard, François, Maxim De Schepper, Tatjana Geukens, et al.. (2023). 14P Comparison of single-cell ERBB2 mRNA expression levels with HER2 status by immunohistochemistry reveals heterogeneity of the HER2-low status. ESMO Open. 8(1). 101238–101238.

Sleurs, Charlotte, et al.. (2023). Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer. Translational Oncology. 37. 101769–101769. 3 indexed citations

Bassez, Ayse, Hanne Vos, Laurien Van Dyck, et al.. (2021). A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nature Medicine. 27(5). 820–832. 442 indexed citations breakdown →

Bempt, Isabelle Vanden, Hans Wildiers, Ann Smeets, et al.. (2021). Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2− early breast cancer. Modern Pathology. 34(7). 1297–1309. 7 indexed citations

10.

Vrieze, Tessa De, Nick Gebruers, Ines Nevelsteen, et al.. (2020). Physical activity level and age contribute to functioning problems in patients with breast cancer-related lymphedema: a multicentre cross-sectional study. Supportive Care in Cancer. 28(12). 5717–5731. 20 indexed citations

11.

Vrieze, Tessa De, Nick Gebruers, Ines Nevelsteen, et al.. (2020). Responsiveness of the Lymphedema Functioning, Disability, and Health Questionnaire for Upper Limb Lymphedema in Patients with Breast Cancer-Related Lymphedema. Lymphatic Research and Biology. 18(4). 365–373. 13 indexed citations

12.

Thomis, Sarah, Lore Dams, Inge Fourneau, et al.. (2020). Correlation Between Clinical Assessment and Lymphofluoroscopy in Patients with Breast Cancer-Related Lymphedema: A Study of Concurrent Validity. Lymphatic Research and Biology. 18(6). 539–548. 16 indexed citations

13.

Deman, Frederik, Kevin Punie, Annouschka Laenen, et al.. (2020). Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes. Breast Cancer Research and Treatment. 184(3). 985–998. 9 indexed citations

14.

Vrieze, Tessa De, Thierry Deltombe, Nick Gebruers, et al.. (2020). Cross-cultural validation of the French version of the Lymphedema Functioning, Disability and Health Questionnaire for Upper Limb Lymphedema (Lymph-ICF-UL). Disability and Rehabilitation. 43(19). 2797–2804. 11 indexed citations

15.

Vrieze, Tessa De, Nick Gebruers, Ines Nevelsteen, et al.. (2020). Breast cancer-related lymphedema and its treatment: how big is the financial impact?. Supportive Care in Cancer. 29(7). 3801–3813. 14 indexed citations

16.

Mechelen, Margot Van, Anke Van Herck, Kevin Punie, et al.. (2020). Behavior of metastatic breast cancer according to subtype. Breast Cancer Research and Treatment. 181(1). 115–125. 32 indexed citations

17.

Vrieze, Tessa De, Nick Gebruers, Ines Nevelsteen, et al.. (2019). Reliability of the MoistureMeterD Compact Device and the Pitting Test to Evaluate Local Tissue Water in Subjects with Breast Cancer-Related Lymphedema. Lymphatic Research and Biology. 18(2). 116–128. 23 indexed citations

18.

Vrieze, Tessa De, Nick Gebruers, An De Groef, et al.. (2019). Revision of the Lymphedema Functioning, Disability and Health Questionnaire for Upper Limb Lymphedema (Lymph-ICF-UL): Reliability and Validity. Lymphatic Research and Biology. 17(3). 347–355. 37 indexed citations

19.

Vrieze, Tessa De, Ines Nevelsteen, Sarah Thomis, et al.. (2019). What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review. Supportive Care in Cancer. 28(2). 439–449. 55 indexed citations

20.

Kindts, I., Annouschka Laenen, Stéphanie Peeters, et al.. (2016). Validation of the Web-Based IBTR! 2.0 Nomogram to Predict for Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy. International Journal of Radiation Oncology*Biology*Physics. 95(5). 1477–1484. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact